soul study semaglutide Post hoc analysis of SUSTAIN 6 and PIONEER 6 trials suggests that people with type 2 diabetes at high cardiovascular risk treated with experience more stable kidney function compared with placebo soul study semaglutide New data

Fitaros unique formulation offers an advanced therapeutic option, providing not only glycemic control but also addressing the challenging aspects of weight management

Weight management becomes significantly harder for people living with thyroid disease, as metabolism directly depends on thyroid hormone levels

EMBO Journal

Women planning pregnancy should stop semaglutide at least 2 months before conception due to the long half-life of the drug

We found that LPS treatment increased expression of AD-associated genes in specific cell populations: microglia (BH-adjusted P = 1.6 10 8 ), pericytes1 (BH-adjusted P = 1.8 10 4 ), endothelial cells (BH-adjusted P = 3.1 10 8 ), Mobp -expressing oligodendrocytes (BH-adjusted P = 2.3 10 4 ), and CA1 Satb2 neurons (BH-adjusted P = 3.4 10 3